Pharming Group N.V. - ROE
PHGUF
Price:
$1.15
Market Cap:
$915.16M
Pharming Group N.V. operates as a biopharmaceutical firm focused on creating and commercializing protein replacement therapies and precision medicines. These specialized treatments target rare diseases and areas with critical unmet medical needs, reaching patients throughout the United States, Europe, and other international regions. Pharming's flagship therapeutic is Ruconest, a genetically engineered human C1 esterase inhibitor designed to manage acute episodes of hereditary angioedema. Beyond its primary offering, the company's pipeline actively explores the use of rhC1INH for conditions such as pre-eclampsia, acute kidney injury, and COVID-19. Additionally, Pharming is developing lenioli...[Read more]
Industry
Biotechnology
IPO Date
2002-05-08
Stock Exchange
OTC
Ticker
PHGUF
PE Ratio
[57.50]
ROE
[4.75%]
Current Ratio
[2.63]
Dividend Yield
[0%]
Enterprise Value
[978.19M]
Dividend History
The ROE as of June 2026 (TTM) for Pharming Group N.V. (PHGUF) is 4.75%
According to Pharming Group N.V.’s latest financial reports and current stock price. The company's current ROE is 4.75%. This represents a change of 292.93% compared to the average of 1.21% of the last 4 quarters.
Pharming Group N.V. (PHGUF) Historical ROE (quarterly & annually)
How has PHGUF ROE performed in the past?
The mean historical ROE of Pharming Group N.V. over the last ten years is -42.27%. The current 4.75% ROE has changed -111.23% with respect to the historical average. Over the past ten years (40 quarters), PHGUF's ROE was at its highest in in the December 2018 quarter at 24.25%. The ROE was at its lowest in in the June 2017 quarter at -367.36%.
Average
-42.27%
Median
3.88%
Minimum
-473.29%
Maximum
46.30%
Pharming Group N.V. (PHGUF) ROE by Quarter and Year
Discovering the peaks and valleys of Pharming Group N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 604.88%
Maximum Annual ROE = 46.30%
Minimum Annual Increase = -172.15%
Minimum Annual ROE = -473.29%
| Year | ROE | Change |
|---|---|---|
| 2025 | 1.07% | -121.54% |
| 2024 | -4.97% | 3.09% |
| 2023 | -4.82% | -172.15% |
| 2022 | 6.68% | -28.92% |
| 2021 | 9.40% | -62.80% |
| 2020 | 25.27% | -34.81% |
| 2019 | 38.76% | -16.27% |
| 2018 | 46.30% | -109.78% |
| 2017 | -473.29% | 604.88% |
| 2016 | -67.14% | 47.04% |
Pharming Group N.V. (PHGUF) Average ROE
How has PHGUF ROE performed in the past?
The current ROE of Pharming Group N.V. (PHGUF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.91%
5-year avg
1.47%
10-year avg
-42.27%
Pharming Group N.V. (PHGUF) ROE vs. Peers
How is PHGUF’s ROE compared to its peers?
Pharming Group N.V.’s ROE is less than Idorsia Ltd (19.23%), greater than Ascletis Pharma Inc. (-18.93%), greater than SanBio Company Limited (-44.85%), less than Life Healthcare Group Holdings Limited (60.46%), less than Netcare Limited (16.93%), less than Rhoen-Klinikum AG (3.04%), less than Safilo Group S.p.A. (12.37%), greater than Valneva SE (-106.22%), less than Life Healthcare Group Holdings Limited (60.46%), less than Genomma Lab Internacional, S.A.B. de C.V. (14.77%),
| Company | ROE | Market cap |
|---|---|---|
| 19.23% | $1.91B | |
| -18.93% | $1.42B | |
| -44.85% | $1.28B | |
| 60.46% | $1.17B | |
| 16.93% | $843.64M | |
| 3.04% | $1.02B | |
| 12.37% | $1.13B | |
| -106.22% | $489.29M | |
| 60.46% | $880.08M | |
| 14.77% | $821.31M |
Build a custom stock screener for Pharming Group N.V. (PHGUF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharming Group N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Pharming Group N.V. (PHGUF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Pharming Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Pharming Group N.V.'s ROE?
How is the ROE calculated for Pharming Group N.V. (PHGUF)?
What is the highest ROE for Pharming Group N.V. (PHGUF)?
What is the 3-year average ROE for Pharming Group N.V. (PHGUF)?
What is the 5-year average ROE for Pharming Group N.V. (PHGUF)?
How does the current ROE for Pharming Group N.V. (PHGUF) compare to its historical average?